We focused on a subset of CD4‐derived double‐negative T (DNT) cells called TCRαβ+NK1.1−CD4−CD8− for treating Alzheimer's disease, and we found their injection can improve cognition of the 5×FAD mouse model. This evidence concerns the gene CD4 and Alzheimer disease.